Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer

Annals of Oncology

Volumn 7, Issue 1, 1996, Pages 75-81

  Nooter, K ^a,d   Bosman, F T ^b   Burger, H ^a   Van Wingerden, K E ^a   Flens, M J ^c   Scheper, R J ^c   Oostrum, R G ^a   Boersma, A W M ^a   Van Der Gaast, A ^a   Stoter, G ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Immunohistochemistry; MRP; NSCLC; RNase protection assay

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 13344278064     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010484     Document Type: Article

References (29)

1. Roninson IB. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. New York: Plenum 1991.
2. Clynes M. Multiple Drug Resistance in Cancer. Cellular, Molecular and Clinical Approaches. Dordrecht: Kluwer Academic Publishers 1993.
3. Doyle AL. Mechanisms of drug resistance in human lung cancer. Semin Oncol 1993; 20; 326-37.
4. Cole SPC, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington, DC) 1992; 258: 1650-4.
5. Hipfner DR, Gauldie SD, Deeley RG et al. Detection of the Mr 190.000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994; 54: 5788-92.
6. Childs S, Ling V. The MDR superfamily of genes and its biological implications. In De Vita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology 1994. Philadelphia: Lippincott 1994; 21-36.
7. Grant CE, Valdimarsson G, Hipfner DR et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-61.
8. Kruh GD, Can A, Myers K et al. Expression of complementary DNA library transfer establishes MRP as a multidrug resistance gene. Cancer Res 1994; 54: 1649-52.
9. Zaman GJR, Flens MJ, van Leusden MR et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994; 91: 8822-6.
10. Cole SPC, Sparks KE, Fraser K et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994; 54: 5902-10.
11. Burger H, Nooter K, Zaman GJR et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 1994; 8: 990-7.
12. Burger H, Nooter K, Sonneveld P et al. Higher expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukemia. Br J Haematol 1994; 88: 348-56.
13. Abbaszadegan MR, Futscher BW, Klimecki WT et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 1994; 54: 4676-79.
14. Bordow SB, Haber M, Madafiglio J et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and Overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 1994; 54: 5036-40.
15. Thomas GA, Barrand MA, Stewart S et al. Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissues as determined by in situ hybridisation. Eur J Cancer 1994; 30A: 1705-9.
16. Fellous M, Nir U, Wallach D et al. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA 1982; 79: 3082-6.
17. Zaman GJR, Versantvoort CHM. Smit JJM et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug-resistant lung cancer cell lines. Cancer Res 1993; 53: 1747-50.
18. Flens MJ, Izquierdo MA, Scheffer GL et al. Immunochemical detection of multidrug resistance-associated protein MRP in human multidrug-resistant tumour cells by monoclonal antibodies. Cancer Res 1994; 54: 4557-63.
19. Hofmann GA, Mattern MR. Topoisomerase II in multiple drug resistance. Cytotechnology 1993; 12: 137-54.
20. Moscow JA, Dixon KH. Glutathione-related enzymes, glutathione and multidrug resistance. Cytotechnology 1993; 12: 155-70.
21. Chan HSL, Thorner PS, Haddad G et al. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689-704.
22. Bourhis J, Benard J, Hartmann O et al. Correlation of mdrl gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 1989; 8: 1501-5.
23. Nooter K, Sonneveld P. Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Res 1994; 18: 233-43.
24. Lai SL, Goldstein LJ, Gottesman MM et al. MDR1 gene expression in lung cancer. J Natl Cancer Inst 1989; 81: 1144-50.
25. Goldstein LJ, Galski H, Fojo AT et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-24.
26. Weinstein RS, Jakate SM, Dominguez JM et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991; 51: 2720-6.
27. Jedlitschky G, Leier I, Buchholz U et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994; 54: 4833-6.
28. 4 and structurally related conjugates. J Biol Chem 1994; 269: 27807-10.
29. Müller M, Meijer C, Zaman GJR et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione 5-conjugate transport. Proc Natl Acad Sci USA 1994; 91: 13033-7.